Top Markets
Coin of the day
Kaleido Biosciences, Inc. Kaleido Biosciences, Inc.

Kaleido Biosciences, Inc.

KLDO
Classement en actions #42678
Kaleido Biosciences, Inc. is a clinical-stage healthcare firm dedicated to... Kaleido Biosciences, Inc. is a clinical-stage healthcare firm dedicated to pioneering microbiome metabolic therapies. Its pipeline includes specific drug candidates such as KB195 for urea cycle disorders, KB295 targeting ulcerative colitis, KB174 aimed at hepatic encephalopathy, and KB109 for COVID-19. The company is also advancing programs in other significant therapeutic areas, including multi-drug resistant infections, chronic kidney disease, atherosclerotic cardiovascular disease, cardio-metabolic syndrome, immuno-oncology, and various inflammatory bowel conditions. Kaleido maintains strategic collaborations with Institute Gustave Roussy, Washington University, and Janssen. Established in 2015, its headquarters are situated in Lexington, Massachusetts.
Prix de l'action
$0.00001
Dernière synchronisation: 2026-07-30
Capitalisation boursière
$426.00
Changement (1 jour)
0.00%
Changement (1 an)
-90.00%
Pays
US
Échange Kaleido Biosciences, Inc. (KLDO)

Catégorie

Historique du prix de l'action pour Kaleido Biosciences, Inc. (KLDO)
Prix de clôture le plus élevé : $0.00 le 2026-07-01

Prix de clôture le plus bas : $14.23 le 2019-02-01
Historique du prix de l'action de Kaleido Biosciences, Inc. de 2019 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 0.00%
2025 304.60%
2024 7.34%
2023 -92.98%
2022 -99.97%
2021 -65.59%
2020 50.15%
2019 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$527.87 36.13%
US
$873.57 37.02%
NL
$736.38 8.73%
CH
$263.09 20.45%
BE
$1.07K -5.56%
KR